RS57740B1 - Ciklezonid za lečenje oboljenja disajnih puteva kod konja - Google Patents

Ciklezonid za lečenje oboljenja disajnih puteva kod konja

Info

Publication number
RS57740B1
RS57740B1 RS20181190A RSP20181190A RS57740B1 RS 57740 B1 RS57740 B1 RS 57740B1 RS 20181190 A RS20181190 A RS 20181190A RS P20181190 A RSP20181190 A RS P20181190A RS 57740 B1 RS57740 B1 RS 57740B1
Authority
RS
Serbia
Prior art keywords
ciclesonide
pharmaceutically acceptable
acceptable salt
composition containing
treatment
Prior art date
Application number
RS20181190A
Other languages
English (en)
Serbian (sr)
Inventor
Balazs Albrecht
Michael Aven
Janine Lamar
Ingo Lang
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS57740(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of RS57740B1 publication Critical patent/RS57740B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
RS20181190A 2012-12-21 2013-12-18 Ciklezonid za lečenje oboljenja disajnih puteva kod konja RS57740B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13811924.3A EP2934479B1 (de) 2012-12-21 2013-12-18 Ciclesonide für die behandlung von atemwegserkrankungen bei pferden
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (1)

Publication Number Publication Date
RS57740B1 true RS57740B1 (sr) 2018-12-31

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181190A RS57740B1 (sr) 2012-12-21 2013-12-18 Ciklezonid za lečenje oboljenja disajnih puteva kod konja

Country Status (24)

Country Link
US (4) US20140179651A1 (de)
EP (1) EP2934479B1 (de)
AR (1) AR094241A1 (de)
AU (2) AU2013360691B2 (de)
BR (2) BR122016029247A2 (de)
CA (1) CA2888428C (de)
CY (2) CY1121115T1 (de)
DK (1) DK2934479T3 (de)
ES (1) ES2693779T3 (de)
FR (1) FR20C1026I1 (de)
HR (1) HRP20181980T1 (de)
HU (1) HUS2000020I1 (de)
IN (1) IN2015DN02894A (de)
LT (2) LT2934479T (de)
MA (1) MA38169B2 (de)
MX (1) MX368306B (de)
NO (1) NO2020014I1 (de)
NZ (1) NZ706573A (de)
PL (1) PL2934479T3 (de)
PT (1) PT2934479T (de)
RS (1) RS57740B1 (de)
SI (1) SI2934479T1 (de)
WO (1) WO2014096115A1 (de)
ZA (1) ZA201502288B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
BR122016029247A2 (pt) 2012-12-21 2019-08-20 Boehringer Ingelheim Vetmedica Gmbh Ciclesonida para o tratamento de doença das vias respiratórias em cavalos e composição que a compreende
HUE051527T2 (hu) 2014-06-18 2021-03-01 Boehringer Ingelheim Vetmedica Gmbh Muszkarin-antagonisták és kombinációik légúti betegség lovakban történõ kezelésére
KR102035478B1 (ko) * 2016-10-14 2019-10-23 제주대학교 산학협력단 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물
US20230033224A1 (en) * 2020-01-10 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
MX2023001201A (es) 2020-07-31 2023-05-03 Chemo Res S L Terapia combinada para la administracion por inhalacion.

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
AU2003272450A1 (en) 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
AU2004241746A1 (en) 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
JP2008504341A (ja) 2004-06-29 2008-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドと抗コリン作用剤とを含む吸入用薬剤
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
ES2593428T3 (es) 2009-06-25 2016-12-09 Boehringer Ingelheim Vetmedica Gmbh Inhalador
US7829748B1 (en) * 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
US20150202297A1 (en) 2012-07-05 2015-07-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
WO2014007766A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
BR122016029247A2 (pt) 2012-12-21 2019-08-20 Boehringer Ingelheim Vetmedica Gmbh Ciclesonida para o tratamento de doença das vias respiratórias em cavalos e composição que a compreende
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
CA3129707C (en) 2013-08-20 2023-04-25 Boehringer Ingelheim Vetmedica Gmbh Inhaler
EP4257171A3 (de) 2013-08-20 2023-11-22 Boehringer Ingelheim Vetmedica GmbH Inhalator
HUE051527T2 (hu) 2014-06-18 2021-03-01 Boehringer Ingelheim Vetmedica Gmbh Muszkarin-antagonisták és kombinációik légúti betegség lovakban történõ kezelésére

Also Published As

Publication number Publication date
HUS2000020I1 (hu) 2020-07-28
BR112015010842A8 (pt) 2019-10-01
LTPA2020511I1 (lt) 2020-07-27
NO2020014I1 (no) 2020-06-12
MA38169B2 (fr) 2021-08-31
IN2015DN02894A (de) 2015-09-11
BR112015010842B1 (pt) 2021-03-30
ZA201502288B (en) 2019-09-25
NZ706573A (en) 2019-11-29
PL2934479T3 (pl) 2019-02-28
FR20C1026I1 (fr) 2020-10-02
CY2020015I2 (el) 2021-03-12
MX368306B (es) 2019-09-27
AR094241A1 (es) 2015-07-22
AU2018201642B2 (en) 2019-01-31
CY2020015I1 (el) 2020-11-25
US20180153907A1 (en) 2018-06-07
EP2934479B1 (de) 2018-09-19
EP2934479A1 (de) 2015-10-28
US10258634B2 (en) 2019-04-16
PT2934479T (pt) 2018-12-20
CA2888428A1 (en) 2014-06-26
US10441597B2 (en) 2019-10-15
AU2013360691A1 (en) 2015-04-16
MX2015007947A (es) 2015-10-08
CA2888428C (en) 2021-07-13
US9918995B2 (en) 2018-03-20
US20140179651A1 (en) 2014-06-26
CY1121115T1 (el) 2019-12-11
US20170079988A1 (en) 2017-03-23
AU2013360691B2 (en) 2018-03-08
ES2693779T3 (es) 2018-12-13
LT2934479T (lt) 2018-12-27
MA38169A1 (fr) 2017-01-31
BR122016029247A2 (pt) 2019-08-20
US20150313918A1 (en) 2015-11-05
WO2014096115A1 (en) 2014-06-26
BR112015010842A2 (pt) 2017-07-11
AU2018201642A1 (en) 2018-03-29
DK2934479T3 (en) 2018-11-05
HRP20181980T1 (hr) 2019-01-25
SI2934479T1 (sl) 2019-01-31

Similar Documents

Publication Publication Date Title
US10441597B2 (en) Ciclesonide for the treatment of airway disease in horses
AU2020202402B2 (en) Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
Edsbäcker et al. Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?
JP2016510012A5 (de)
EP2934544B1 (de) Pharmazeutische formulierung mit ciclesonid
TW200815054A (en) Methods of using a thiazole derivative
WO2019067866A1 (en) GLUCOCORTICOID PARTICLES AND THEIR USE
JP6346618B2 (ja) アクリジニウムの新規用途
US20230033224A1 (en) Ciclesonide for ameliorating quality of life (qol) in equines